Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/14/2008

For the six months ended June 30, 2008, the gross profit margin was 68.5%, compared to 70.9% for the same period in 2007. This modest decrease reflects the increase in the cost of raw materials while the price at which we sell our products has remained constant.

Selling, general and administrative expenses were $5.1 million for the second quarter of 2008, an increase of 50.2% compared to $3.4 million for the same period in 2007. The selling and administrative expenses as a percentage of sales were 25.9% for the second quarter of 2008 compared to 23.7% for the same period in 2007. For the six months ended June 30, 2008, selling, general and administrative expenses were $8.3 million, an increase of 25.3% compared to $6.7 million in the same period in 2007. For the six months ended June 30, 2008, selling, general and administrative expenses as a percentage of sales was 25.7%, compared to 21.8% for the same period in 2007. This increase was primarily due to increases in general administration costs related to the construction of the Life Resources project, salary and insurance expenses, advertising, research and development expenses and the appreciation of the renminbi.

Tiens continues to strive to expand its market share in China through the branches, chain stores, and Chinese affiliated companies of Tianshi Engineering. To enhance its position in this competitive market, Tianshi Engineering continues to increase its marketing activities in China, including opening additional branches across China, developing a nation-wide advertising campaign, encouraging media coverage and strengthening the Tiens brand.

As of June 30, 2008, Tiens had $86.9 million of retained earnings and total shareholders' equity of $128.3 million.

Jinyuan Li, Chairman, President and CEO of Tiens, said, "We are pleased with the increase in both domestic and international revenues over last year's second quarter and our sequential growth compared to the first quarter of
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
2. Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
3. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
4. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. ThirdBiotech Announces Kemeta as Newest Sponsor
7. Yongye Biotechnology International Retains CCG Investor Relations
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A
11. New Book on the Business of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...LGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics ...or the "Company") today announced updated results ...n patients with sarcomas metastatic to the lung in...ve Tissue Oncology Society Meeting held in Miami B...r presentation, entitled "A Phase II Study of Intr...
(Date:11/5/2009)...ITHERSBURG, Md., Nov. 5 ...financial results for the third quarter ended Sept... million ($0.04 per share) for the three months en...6.8 million ($0.08 per share) in the comparable qu... 30, 2009, GenVec,s net loss was $14.1 million ($0...
(Date:11/5/2009)...NCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCall...ng supplier of innovative products for processing ...ts for the first quarter of fiscal 2010. ,, For... reported revenues of $5.2 million, a 15 percent i... quarter a year ago. The Company said the key cont...
(Date:11/5/2009)...NNYVALE, Calif., Nov. 5 ...executives will be speaking at the following inves...ate via webcast. , , Credit Suisse... Thursday, 12 November, 2009 at 10 a.m. Mountain...rogram, London, England, Tuesday, ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...witzerland, August 25 Mymetics,Corporation (OTCBB...n will,be made available via Standard & Poor,s Mar...rvice that enables subscribing publicly traded,com...ted to users of,Standard & Poor,s Advisor Insight....ugh this program includes share price, volume, div...
...s Stephen Ross Senior Vice President of Commercial... of Human Resources, CLINTON, N.J., Aug. 25 Ikar...e biotherapeutics company, announced today the,add...ppointed Senior Vice,President of Commercial Opera...dent for Human Relations., Daniel Tasse, Presiden...
...witzerland, August 25 Mymetics,Corporation (OTC: ...l on,Wednesday August 27th 2008 at 1 PM New York T...ess of the company, the June 30th 2008 Form 10-Q a...n the call Toll Free from the US at +1-866-591-436...IN 815 726., Corporate description:, Mymetics, p...
Other Biology Technology:Mymetics Corporation Information to be Available Through Standard & Poor's Market Access Program 2Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership 2
(Date:11/6/2009)...nth of the publication of On the Origin of Species...IBS) is publishing open access two peer-reviewed a...ghts into evolution. , The two articles are by Ke...ey, and James T. Costa of Western Carolina Univers...rwin," appeared in the October issue of the AIBS j...
(Date:11/6/2009)... Hills, MI-based Law Enforcement Intelligent Devic...m and patent-pending Biometric Access Control Syst... Human Services, National Institutes of Health (NI...support the NIH,s entire police force that is resp...ch agency. The project is expected to be complete...
(Date:11/5/2009)...rs (NABT) will recognize Leonard C. Yannielli, pro...Community College (NVCC) in Waterbury, Connecticut...he NABT annual professional development conference...o. , The Evolution Education Award is cosponsore...,(AIBS) and Biological Sciences Curriculum Study ...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Survivors of Childhood Cancer Less Likely to Marry 59113 1Survivors of Childhood Cancer Less Likely to Marry 59113 2Survivors of Childhood Cancer Less Likely to Marry 59113 3Survivors of Childhood Cancer Less Likely to Marry 59113 4High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 1High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 2High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 3High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 4Two Hutchinson Center Scientists Receive a Total of 2416 7 Million for Collaborative Stem Cell Research 5313 1Two Hutchinson Center Scientists Receive a Total of 2416 7 Million for Collaborative Stem Cell Research 5313 2
...studying fuels from biomass for years. Now, with g...nscious society emerging, biofuels are fast becomi...s all across America. , Ethanol blends are alrea...availability varies from state to state, depending...mass for biofuel production in each state also var...
... United Nations called for a Green Revolution in A... promise of fighting hunger in Africa through agri... agriculture, nutrition, environment, markets and ...e African Green Revolution Takes Shape, on Tuesday...rnest N. Morial Convention Center in New Orleans. ...
...cane Katrina devastated New Orleans and parts of t...aders will share lessons learned during the Intern... Agronomy (ASA), Crop Science Society of America (...Nov. 7-8 at the Ernest N. Morial Convention Center...r and Sustainable Coastal Development: An Integrat...
Other Biology News:The race for biofuels driving alternative sources of biomass 2Now is Africa's turn for a green revolution, global experts say 2Soil, conservation experts to reflect on Hurricane Katrina disaster 2
...IRsolution software provides quick and easy operat...-based control. The software is fully secure and ...lations, and compatible with user-created macros f...nables use in high-level research and development ...
Mouse Anti-Xenopus laevis Xenopus nuclear factor Antibody, Unconjugated from Developmental Studies Hybridoma Bank
...The PerkinElmer kit provides reagents for immune c...xes in serum and plasma samples using a combinatio...ized and transferred to microplate wells which are...tibody to HIV-1 p24. The immobilized monoclonal an...
Mitochondria Isolation Kit for Tissue and Cultured Cells from BioChain
Biology Products: